Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

128 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.
Fagugli RM, De Smet R, Buoncristiani U, Lameire N, Vanholder R. Fagugli RM, et al. Among authors: buoncristiani u. Am J Kidney Dis. 2002 Aug;40(2):339-47. doi: 10.1053/ajkd.2002.34518. Am J Kidney Dis. 2002. PMID: 12148107 Clinical Trial.
Birth and evolution of the "Y" set.
Buoncristiani U. Buoncristiani U. ASAIO J. 1996 Jan-Feb;42(1):8-11. ASAIO J. 1996. PMID: 8808449 Review. No abstract available.
Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
Fagugli RM, Vanholder R, De Smet R, Selvi A, Antolini F, Lameire N, Floridi A, Buoncristiani U. Fagugli RM, et al. Among authors: buoncristiani u. Int J Artif Organs. 2001 May;24(5):256-62. Int J Artif Organs. 2001. PMID: 11420874 Clinical Trial.
Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: a preliminary characterization.
Buoncristiani U, Galli F, Rovidati S, Albertini MC, Campus G, Canestrari F. Buoncristiani U, et al. Nephron. 1997;77(1):57-61. doi: 10.1159/000190247. Nephron. 1997. PMID: 9380239 Clinical Trial.
Daily dialysis: long-term clinical metabolic results.
Buoncristiani U, Quintaliani G, Cozzari M, Giombini L, Ragaiolo M. Buoncristiani U, et al. Kidney Int Suppl. 1988 Mar;24:S137-40. Kidney Int Suppl. 1988. PMID: 3163035 No abstract available.
Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors.
Brugnano R, Francisci D, Quintaliani G, Gaburri M, Nori G, Verdura C, Giombini L, Buoncristiani U. Brugnano R, et al. Among authors: buoncristiani u. Nephron. 1992;61(3):263-5. doi: 10.1159/000186899. Nephron. 1992. PMID: 1323768
Effect of daily hemodialysis on monocytes apoptosis.
Andrikos E, Buoncristiani E, D'Intini V, Bordoni V, Bonello M, Levin N, Buoncristiani U, Pappas M, Ronco C. Andrikos E, et al. Among authors: buoncristiani e, buoncristiani u. Blood Purif. 2005;23(1):79-82. doi: 10.1159/000082015. Blood Purif. 2005. PMID: 15627741 Clinical Trial.
Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels.
Barril G, Bartolomé J, Sanz P, Buoncristiani E, Traver JA, Selgas R, Buoncristiani U, Castillo I, Quiroga JA, Carreño V. Barril G, et al. Among authors: buoncristiani u. J Med Virol. 2010 May;82(5):763-7. doi: 10.1002/jmv.21469. J Med Virol. 2010. PMID: 20336716
The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels.
Galli F, Benedetti S, Buoncristiani U, Piroddi M, Conte C, Canestrari F, Buoncristiani E, Floridi A. Galli F, et al. Among authors: buoncristiani u, buoncristiani e. Kidney Int. 2003 Aug;64(2):748-55. doi: 10.1046/j.1523-1755.2003.00134.x. Kidney Int. 2003. PMID: 12846775 Clinical Trial.
Rationale for Daily Dialysis.
Buoncristiani U, Fagugli R, Quintaliani G, Kulurianu H. Buoncristiani U, et al. Home Hemodial Int (1997). 1997 Jan;1(1):12-18. doi: 10.1111/hdi.1997.1.1.12. Home Hemodial Int (1997). 1997. PMID: 28466596
128 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback